ATRX and central nervous system cancer: Alpha Thalassemia/Mental Retardation Syndrome X-Linked (ATRX) loss is frequently identified in gliomas and may be a molecular marker for DNA damage response defects and ATRX knock-out led to PARP inhibitor sensitivity in glioma cells [50].